クイックアンサー
Butterfly iQ3 is a strong cloud-first POCUS platform, but it is not the automatic best fit for every clinic.
- Choose Butterfly iQ3 when your team values a polished app, cloud workflow, education tools, AI features and broad POCUS presets.
- Compare Suresult D3Ultra when first-year ownership cost, iOS / Android / Windows flexibility and no required software subscription matter more.
- Compare Vscan Air or Lumify when the buyer prefers an established hospital ultrasound ecosystem.
- Compare Clarius when the main need is a dedicated high-frequency or specialty wireless probe.
- Do not buy by device price alone. Compare membership, storage/export, supported devices, warranty and regional delivery before ordering.
Quick List: how we would shortlist Butterfly iQ3 alternatives
バタフライiQ3
Choose it when your team values the Butterfly cloud, AI and education ecosystem enough to manage membership, device and workflow constraints.
スールスルト D3Ultra
Compare it when predictable ownership cost, iOS/Android/Windows access and local export workflow matter more than a cloud-first platform.
Vscan Air / Lumify
Shortlist these when procurement prefers a familiar enterprise manufacturer and accepts a more conventional platform decision.
クラリアス
Compare Clarius when a dedicated wireless scanner and polished specialty app experience matter more than one broad all-in-one probe.
Buy Butterfly iQ3 if
- You value a polished cloud and app ecosystem more than the lowest ownership cost.
- Your users are comfortable working mainly from supported mobile devices.
- You want broad POCUS coverage from a single handheld platform.
もし~なら、よく比較してください
- You need DICOM/PACS, image storage, education, reporting or team workflow features that may depend on membership tiers.
- Your clinic uses mixed Android, iOS and Windows devices.
- You need predictable landed cost outside the US.
Consider Suresult if
- You want handheld ultrasound with no required software subscription.
- You want Windows, Android and iOS software access.
- You prefer scanner cost plus included software and clear delivery terms.
| 購入者からの質問 | バタフライiQ3 | What to compare |
|---|---|---|
| Who is it best for? | Clinics or POCUS programs that like a cloud-first ecosystem, training content, AI tools and one-probe convenience. | Private clinics that want simpler ownership cost and broader display-device flexibility should compare D3Ultra, Lumify, Vscan Air and Clarius routes. |
| Published price signal | Butterfly lists iQ3 at $3,899, with Core Technology at $299/year, Advanced Technology at $420/year, and an Advanced one-time option at $1,500 where available. | Compare first-year cost, software renewals, storage/export needs, warranty and regional delivery terms rather than device price alone. |
| Display-device workflow | Butterfly publishes compatibility requirements and supported-device lists for iOS and Android. | If a clinic uses Windows tablets, shared workstations or mixed-device rooms, confirm the workflow before purchase. |
| Clinical positioning | Strong broad POCUS positioning and a mature software ecosystem. | Dedicated linear, phased or multipurpose crystal-based probes may still make more sense for narrower imaging tasks. |
This review is intentionally buyer-focused. We are not saying Butterfly iQ3 is a bad scanner. We are saying that its best buyer is specific: a team that values the Butterfly ecosystem enough to accept the software, device and workflow tradeoffs.
A Short Intro to Butterfly iQ3
バタフライiQ3 represents the third generation of Butterfly’s semiconductor-based imaging technology following the earlier iQ and iQ+. While the previous models established the concept of “ultrasound-on-chip,” the iQ3 refined that technology with improved image processing and expanded software capabilities.
Unlike standard ultrasound machines that use piezoelectric crystals, the iQ3 relies on a semiconductor-based CMUT (Capacitive Micromachined Ultrasonic Transducer) array with approximately 9,000 micro-machined elements on a single silicon chip. This allows the probe to electronically emulate:
- Linear array (for vascular access, MSK, small parts)
- Curvilinear/convex array (for abdominal, OB, FAST exams)
- Phased array (for cardiac imaging)
This allows the user to toggle between 1-12 MHz frequencies and beam shapes digitally rather than physically swapping hardware.
Prominent Features of the iQ3:
- Multiple Imaging Modes: B-Mode, M-Mode, Color Doppler, Power Doppler, and Pulsed-Wave Doppler (note: some require higher subscription tiers).
- Wired Data Connection: The probe has its own battery (charged wirelessly) but transmits data via USB-C or Lightning cable.
- Advanced Guidance Features: Tools such as Needle Viz™ and biplane imaging (which allows clinicians to view longitudinal and transverse planes simultaneously in real-time) are a major boon for guided procedures.
- AI-powered Tools: iQ Slice™ & iQ Fan™ are designed to automate volume capture and provide haptic/visual feedback to help novices find the optimal acoustic window.
- Comprehensive Preset Library: Over 25 clinical presets covering everything from high-frequency vascular access to deep cardiac and obstetric imaging.
- Cloud-Centric Workflow: Automatic uploading of studies to the Butterfly Cloud for seamless peer review, QA, and billing integration.
Is the Butterfly iQ3 Right For You? (Quick Check)
Before diving into the full technical review, here is a fast self-assessment. The iQ3 is an impressive device, but it is not the right fit for every clinician or practice.
Check whether you recognize yourself in any of these profiles:
- The Android Power User (especially outside North America): The iQ3 only supports a narrow whitelist of Snapdragon-powered flagship phones, primarily US and Canadian variants. If you use a Samsung with an Exynos chip, a Xiaomi, a OnePlus, or virtually any non-North American flagship, your device may simply not work, or may go unsupported for months after launch.
- The Proceduralist: If your primary use case is ultrasound-guided central lines, nerve blocks, or joint injections, the wired cable is a genuine liability. It comes with a risk of breaking the sterile field or damaging your phone’s charging port, outweighing the “all-in-one” convenience.
- The Budget-Conscious Private Practice: When you factor in the $3,899 upfront cost plus the mandatory subscription ($420/year minimum for basic clinical tools), your five-year total cost of ownership climbs past $6,000. For a practice that only needs basic vascular or MSK imaging, a “no-subscription” crystal-based alternative provides better long-term ROI.
- The High-Volume Academic Center: Authenticating dozens of individual user seats, keeping every mobile device on the approved hardware list, and routing all images through a proprietary cloud before they reach your PACS is an administrative and IT burden that scales poorly. The dependency on Butterfly’s ecosystem introduces friction that your operations team will feel.
If you recognize yourself in any of these profiles, the iQ3 is likely not your best option. Start with the Recommendations section below for alternatives that are likely better suited to your workflow, devices, and budget.
If you want the full breakdown of why, including the technical specifics behind each limitation, keep scrolling for the complete deep-dive review below.
Butterfly iQ3 Review: Practical Tradeoffs Buyers Should Check
While the technical specifications are impressive on paper, several operational and clinical limitations of the Butterfly iQ3 are often underemphasized in its marketing. Below are areas that deserve careful consideration before making an investment.
1. Wired Design Limits True Point-of-Care Flexibility
Although marketed as highly portable, the iQ3 is not a wireless device. It requires a physical cable connection to a smartphone or tablet for data transmission. While this provides a stable data stream, it introduces several mechanical and procedural constraints.
A- Poor Ergonomics:
From a clinical perspective, the physical tether can:
- Limit probe angulation in tight procedural spaces.
- Increase strain when scanning in awkward patient positions.
- Add drag during dynamic exams such as cardiac views or lung sweeps.
For example, if you’re doing a FAST exam in a crowded trauma bay or an echocardiogram on a patient with limited mobility, the cable can potentially get tangled in bedside railings, IV lines, or the clinician’s own clothing.
B- Wear and Tear:
The constant plugging and unplugging of the cable also increases mechanical stress on both the probe and the host device’s charging port. For a tablet or smartphone used daily in a clinical environment, this “port wear” often becomes the first point of hardware failure, potentially rendering an expensive display device unusable.
C- Heavier Body:
Unlike some competitors ( GE Vscan Air) that draw power from the host device, the iQ3 contains its own internal battery. This results in a heavier unit (300g/0.66 lbs). While this protects your phone’s battery life, the combined weight of the probe and the resistance of the cable can lead to significant operator fatigue during long scanning sessions or back-to-back rounds.
D- Contamination risk:
During sterile procedures (central line placement, regional nerve block, or a joint aspiration), a cable can act as a “fomite bridge” between the non-sterile mobile device and the sterile procedural site.
While the probe itself can be sheathed, the trailing cable must be meticulously managed to prevent it from swinging into the sterile field. This adds unnecessary prep time and complexity to the workflow.
E- Added Costs:
Operationally, cables are consumables. Over time, replacement cables and damaged connectors add to the total cost of ownership (TCO) and cause unexpected downtime, factors often overlooked during initial procurement.
2. Limited and Region-Specific Android Compatibility
One of the most significant but underappreciated limitations of the iQ3 is its highly restrictive Android compatibility.
Because the iQ3 relies heavily on the host device’s processor to reconstruct images from raw silicon data, it requires high-performance chipsets and stable high-bandwidth USB-C OTG connections. This has led to a relatively narrow “whitelist” of officially supported Android devices.
A- The Snapdragon vs. Exynos Gap:
Butterfly famously does not support international Samsung models using Exynos chipsets (manufactured and used worldwide). Only Snapdragon-powered flagship models (primarily U.S./Canada variants) consistently meet the performance requirements. If you do not own a high-end, US-spec flagship phone, the iQ3 may simply not work.
This creates a massive hurdle for international clinicians using “Pro” or “Ultra” Android hardware from brands like Xiaomi or OnePlus that aren’t on the official list.
B- Difficulty with New Devices:
Even when using an approved brand, newly released flagship models (like the latest Google Pixel or Samsung Galaxy) are often not supported immediately. The Butterfly app requires the engineering team to “verify” each specific model, a process that can take 6–8 weeks post-launch.
This lack of “plug-and-play” universality is a significant contrast to competitors that offer broader OS compatibility.
C- Limited Scalability:
Operationally, dependence on a narrow range of supported hardware makes it difficult for large facilities to deploy the iQ3 at scale, especially in international or resource-constrained settings.
Facilities outside North America may also find it significantly harder to deploy compatible Android devices for every user. This single limitation alone often justifies considering alternative handheld systems with broader, hardware-agnostic compatibility.
3. iOS-First Feature Availability and Platform Gaps
While Butterfly markets the iQ3 as a cross-platform solution, there is a distinct disparity between the Apple and Android user experiences. Historically, Butterfly’s development cycle prioritizes iOS, leaving Android users with a “lite” version of the software that often lacks the newest, most innovative tools.
A- iOS Specific Features
Many of the iQ3’s “headline” features, the very tools used to justify its premium price point, are often iOS-exclusive or significantly delayed on Android. These include:
- テレガイダンス (Real-time remote clinical support.)
- iQスライス
- iQファン
- Volumetric capture tools
The reason is largely technical as Apple’s tightly controlled hardware ecosystem allows for easier optimization, but the practical effect is a tiered class system among users. For a clinician choosing Android for institutional, financial, or personal reasons, this means paying the same subscription and hardware costs as an iPhone user while receiving a restricted subset of the functionality.
B- Fragmented Workflows:
In a multi-user clinical environment, this creates a “software silo.” For example, if one clinician relies on advanced scanning guidance available only on iOS, but a colleague uses Android, it complicates training and quality assurance (QA) protocols.
As you cannot assume every user has access to identical tools, the department becomes dependent on which phone the clinician happens to have in their pocket.
In short, the iQ3 does not deliver a truly platform-neutral experience. The highest-tier experience is more consistently realized on iOS devices.
4. Image Quality Is Improved, but Still Uneven by Application
There is no question that the iQ3 improves upon its predecessors. Compared to the original iQ and iQ+, noise reduction and harmonic imaging have progressed significantly. However, even with these gains, it must contend with the fundamental physics of ultrasound.
Traditional probes use piezoelectric crystals, which are physically optimized for specific tasks. The iQ3’s silicon sensors must “emulate” these crystals through software, which can lead to trade-offs in raw image fidelity.
For common POCUS indications, FAST exams, bladder scans, vascular access, and basic lung assessment, the image quality is generally adequate. But clinicians have reported challenges in:
- Deep-tissue imaging (e.g., a difficult-to-visualize gallbladder in a high-BMI patient)
- Detailed cardiac assessments require optimal penetration and temporal resolution.
- Subtle low-contrast pathologies like early-stage gallstones or minor pericardial effusions.
Users sometimes need to spend additional time optimizing gain, depth, and preset adjustments to achieve diagnostic-quality images. This adds scanning time, especially for less experienced operators.
From an operational standpoint, if a handheld device is expected to replace multiple dedicated probes but underperforms in a difficult case, the clinician is forced to call for a formal radiology consult. This defeats the primary goal of POCUS: providing rapid, definitive answers at the bedside without supplemental equipment.
5. Butterfly Subscription Model and Long-Term Cost Escalation
One of the most significant hurdles of the iQ3 is its mandatory subscription model. The upfront hardware cost of $3,899 is merely the entry fee; the device functions as “Software as a Service” (SaaS) tethered to physical hardware.
Unlike many competitors that offer optional plans for extras like cloud storage (GE Vscan Air) or flat-purchase for lifetime (Suresult), you must maintain a subscription to operate Butterfly beyond a basic live-view:
- Core ($299/yr): Lacks Pulsed Wave (PW) Doppler, TeleGuidance, and key AI tools.
- Advanced ($420/yr): Necessary for basic clinical tools like M-Mode and PW Doppler. (Still no study tagging and exam worksheets)
- Clinical ($3,500/yr): Required for enterprise environments (5 seats).
Over a five-year ownership period, the total cost for a single user climbs toward $6,000. This narrows the price gap between the iQ3 and traditional crystal-based handhelds that offer “lifetime” software access.
From an operational perspective, this means:
- Additional planning as procurement teams must track renewals, billing compliance, and feature entitlements.
- Expanding to multi-user clinical environments requires enterprise-level licensing.
- In training programs, budget fluctuations could potentially limit access to advanced tools if subscription tiers are downgraded.
Especially, for small practices or independent providers, annual fees may alter the financial return on investment.
Dependency Risk:
If a clinician’s department fails to renew the subscription, or if a private practitioner faces a lean month, the device can effectively become a “paperweight” for anything beyond basic live scanning. The inability to use measurement tools or specialized modes in an emergency because of a lapsed license is a significant administrative liability.
6. Cloud-Dependent Image Storage and CPT Documentation Challenges
The Butterfly iQ3 is fundamentally a “Cloud-First” device. Studies are uploaded, archived, and managed through Butterfly’s cloud platform only. While this allows for seamless synchronization across multiple devices, it means the hardware is essentially a peripheral for a remote server.
If you are working in an area with poor connectivity, such as a rural clinic, a basement ER, or during a home health visit, his dependency introduces risks that are often overlooked during the initial purchase.
A- Extremely Limited Local Storage:
Unlike traditional handhelds that store studies on the display phone/tablet, the iQ3 treats local storage as a temporary “waiting room.”
You can only view images locally 前に they are uploaded. Once pushed to the Butterfly Cloud, the study is purged from the local cache.
To review that scan later, perhaps to show a colleague or a patient, you must have an active internet connection to “pull” it back down. In “dead zones,” your previous work is effectively inaccessible.
B- Stability and Data Risks:
High-resolution POCUS generates substantial data; a single still image ranges from 250KB to 1MB, while cine loops (videos) consume 1–2MB per second. Butterfly explicitly recommends against including a high volume of captures in a single study, as larger files increase the likelihood of upload failures.
In areas with fluctuating Wi-Fi, a comprehensive 20-clip FAST exam can easily stall, resulting in an incomplete or corrupted medical record.
C- Android Outbox Limitations:
The platform disparity mentioned earlier is particularly punishing here. Android users cannot click into studies in the outbox to view captures or study details, even temporarily, like iOS users.
If a study is stuck in the upload queue due to poor connectivity, an Android user has no way to verify the data or review the captures until the upload is successful—a massive disadvantage for POCUS exams.
D- The 30-Day “Lock-Out” Policy:
To ensure subscription compliance, the Butterfly app must “handshake” with the internet every 30 days. If the device remains offline for more than a month, common for disaster relief sets or backup emergency kits, you will be unable to scan entirely.
The device effectively “bricks” itself until it can verify its license online, which could happen at the exact moment an emergency scan is needed.
E- Insurance and Medical-Legal Impact:
From a practice management perspective, these limitations have teeth. To claim CPT reimbursement (e.g., 76705 for a limited abdominal ultrasound), a physician must be able to produce a formal report and permanently archived images during an audit.
If an upload fails due to file size, or if your data becomes inaccessible because of a subscription lapse or a 30-day lockout, you cannot legally bill for those exams. This creates a precarious situation where your ability to generate revenue and maintain a legal “paper trail” is entirely dependent on a third-party server and a mandatory annual fee.
To avoid such cases while using Butterfly iQ3, you’d need to plan for:
- Long-term secondary archival policies
- Contingency plans for data retrieval if service agreements change
7. PACS, DICOM, and Offline Workflow Limitations
Integration into existing hospital imaging infrastructure is a critical consideration for many buyers. While the iQ3 supports cloud-based archiving and offers pathways for DICOM export, its workflow is fundamentally built around the vendor’s proprietary ecosystem “Butterfly Link,” rather than traditional hospital-first PACS architecture.
A- Hidden Integration Costs:
Butterfly Network’s official page currently lists “Basic DICOM (PACS/MWL)” as an “available to purchase” feature on top of the annual subscription (for all core, Advance, and Enterprise tiers). This means that connecting to your hospital’s existing network is not a core feature, but an added expense.
B- The Intermediate Cloud Layer:
Even with DICOM enabled, the data must first be uploaded to Butterfly Cloud before being “pushed” to the hospital’s PACS through Butterfly Link. This introduces an extra point of failure.
- In rural settings, mobile outreach, disaster zones, or military deployments where connectivity is inconsistent, this dependence may complicate documentation and study management.
- In environments with strict cybersecurity protocols or “air-gapped” networks, the mandatory external hop is a significant security and operational hurdle.
- If a facility handles archiving through third party providers, this could add additional friction with their third party integration.
- Operationally, IT departments may need to invest additional time in integration planning, firewall configurations, and user management compared to more PACS-native systems.
Competitors (like Suresult) often offer direct-to-DICOM connectivity through HIPPA compliant secure local channels, allowing the probe to communicate directly with the hospital network without an intermediary cloud, providing much-needed decentralized control.
8. Vendor Lock-In and Product Lifecycle Concerns
The iQ3 is a “black box” piece of technology. Because it is powered by proprietary silicon chips rather than standardized piezoelectric components, it is entirely dependent on Butterfly Network’s ongoing software support and financial stability. This creates a state of vendor lock-in:
Once you commit to the iQ3 platform:
- Your clinical archives reside within the vendor’s cloud environment. Switching to another platform later may require complex data migrations and retraining.
- Your access to the tool you “bought” is governed by shifting subscription tiers. If the company changes its feature entitlements, you may lose access to tools you previously relied on.
- As handheld technology evolves, support for older silicon-on-chip generations may plateau. Unlike crystal-based probes that use standard connectors and can often be used with various software platforms for decades, the iQ3 is a closed-loop system.
Reduced flexibility in a healthcare environment has a measurable negative impact on long-term ROI.
Recommended Handheld Ultrasound Alternatives to Butterfly iQ3
If the constraints of the Butterfly ecosystem don’t align with your clinical needs, here we have some powerful alternatives for you. These devices offer different technological approaches, from “all-in-one” wireless convenience to specialized high-definition crystal arrays for cardiac and procedural work.
1. Broad clinic POCUS alternative: シュアサルト D3-ウルトラ
The Suresult D3-Ultra is designed as a true multi-transducer handheld system, combining convex, linear, and phased functionality within a tri-mode architecture. Unlike semiconductor emulation, it utilizes dedicated frequency configurations (3.2MHz to 10MHz) optimized for each application.
主な特徴
- Fully Wireless Freedom: The D3-Ultra connects via dual-band Wi-Fi, eliminating the need for a cable and protecting your host device’s charging port from wear.
- Crystal-Based Fidelity: With 192 elements and 64 channels, it offers contrast resolution comparable to fully dedicated machines, and superior to early-gen silicon-on-chip models.
- Advanced Imaging Controls: Ability to adjust Gain, Focus, Depth, 8-TGC, Dynamic Range adjustments, and multi-level Noise Reduction (0–4), allows granular image optimization for challenging patients.
- Universal Compatibility: It works seamlessly across iOS, Android, and Windows, offering a level of platform independence that Butterfly lacks.
- Zero Recurring Costs: を $2,960 on promotion, all-inclusive. You get a full Doppler suite (B, M, Color, PW), 25+ smart measurements, and DICOM integration without any annual subscription fees.
For specialized cardiac imaging: Suresult CD2 or GE Vscan Air SL
Cardiac imaging requires high frame rates and deep penetration, areas where traditional crystal sensors still hold the edge over silicon.
A- Suresult CD2
The CD2 is a 2-in-1 wireless handheld device featuring a Phased Array on one side and a Linear Array on the other, making it particularly suited for cardiac plus vascular applications.
主な特徴
- Comprehensive Doppler Capabilities: Includes B, B/M, Color Doppler, Power Doppler (PDI), and Pulsed Wave Doppler without subscription gating.
- Extensive Cardiac Measurements: Supports LVIDd, LVIDs, EF, SV, PS, ED, TAMAX, TAMEAN, PI, RI, S/D ratio, and vessel diameter measurements. This allows for a more structured cardiac evaluation beyond basic heart rate monitoring.
- Compact and Lightweight: At 150g and 126×53×19 mm, it is significantly lighter than many multi-function probes, reducing fatigue during focused cardiac exams.
- Inclusive Pricing: Current pricing around $2,270 (promotion) includes charger, case, shipping, and taxes.
B- GE Vscan Air SL
It is GE’s flagship handheld that combines a sector (phased) and linear array in a fully wireless dual-probe format, designed with a strong focus on structured echocardiography workflows.
主な特徴
- AI-Guided Cardiac Views (Caption AI): The mandatory GE Innovations package subscription includes AI-driven probe guidance that walks users through 10 standard echo views and automatically calculates LVEF once views are obtained.
- Signal Processing Technology: Includes SignalMax™+ XDclear™ and HD-SRI speckle reduction imaging to enhance clarity.
- Wireless Operation: Completely cable-free, with a charging pad included. Scan time is approximately 50 minutes per charge.
- Price Considerations: Although an excellent choice for centers that prioritize AI-driven automation, the initial pricing exceeds $5,000 bundled with the required subscription. (~$500/year).
For MSK and procedural guidance: シュアサルト L10H ガイド
Procedures like nerve blocks and vascular access require precision and a clutter-free field. The シュアサルト L10H ガイド is purpose-built for these high-stakes environments, with particular emphasis on needle guidance.
主な特徴
- High-Frequency Linear Imaging: Operates at 7.5/10 MHz with 192 elements and 32 channels, optimized for superficial structures, tendons, nerves, and vascular mapping.
- Visualized Needle Guidance: Provides real-time in-plane and out-of-plane needle visualization using magnetic tracking. The app displays needle trajectory, improving precision for biopsies, nerve blocks, vascular access, and aesthetic procedures.
- Unmatched Battery Life: With a 5600mAh battery, it offers 5 hours of continuous scanning, nearly tripling the endurance of the iQ3.
- 透明な価格設定: $2,300 (promotion) with all features unlocked. Shipping and taxes included. Published 30-day return window.
Our buyer takeaway: Butterfly iQ3 is easiest to justify when the team actively wants Butterfly’s cloud-first ecosystem. It becomes less obvious when the buyer mainly wants a predictable scanner purchase, local export workflow, mixed-device access, or no required software subscription.
Sources checked
Official sources used for this review
よくあるご質問
Q. Butterfly iQ3 を使用するには、サブスクリプションが必要ですか?
Yes. While the device can perform basic live imaging, essential clinical tools such as M-Mode, Pulsed Wave Doppler, and any image storage or sharing require an annual subscription. Without a paid plan, the device’s functionality is restricted to a “live-view” only mode, making the subscription a critical factor in its high Total Cost of Ownership (TCO).
Q. Butterfly iQ3は、どの携帯電話でも使用できますか?
No. Butterfly maintains a strict “whitelist” of compatible devices. Android users are primarily restricted to US/Canadian flagship Snapdragon models. International versions (such as Samsung Exynos chipsets) are notably unsupported. Additionally, there is often a 6–8 week “verification lag” before the app officially supports newly released phone models.
Q. iQ3は、結晶系プローブよりも心臓画像診断に適していますか?
While the iQ3 is a significant improvement over the iQ+, traditional piezoelectric crystal sensors still generally offer superior contrast resolution and deep-tissue penetration. Silicon-on-chip technology can still struggle with “noise” in difficult cardiac windows compared to the physics of a dedicated phased-array crystal probe.
Q. What happens to my images if I cancel my Butterfly subscription?
If your subscription lapses, you risk losing access to your archived images on the Butterfly Cloud. This presents a serious legal and administrative hurdle for CPT reimbursement, as clinicians must be able to produce stored images during a medical audit to justify billed exams.
Q. Does the Butterfly iQ3 have a replaceable battery?
No. The iQ3 utilizes an integrated lithium-ion battery that cannot be swapped or replaced by the user. Because the battery’s health naturally degrades over 2–3 years of heavy use, the device has a finite lifespan. Once the battery fails, the entire unit typically requires professional service or total replacement.
Q. How does Butterfly handle DICOM and PACS integration?
Unlike many competitors that include DICOM as a standard feature, Butterfly often treats DICOM/PACS transfer as an add-on purchase in addition to the annual subscription. Furthermore, it does not offer a direct local connection; images must first be uploaded to the Butterfly Cloud before being pushed to your hospital’s PACS, creating a dependency on external internet connectivity.
Q. Is the Butterfly iQ3 compatible with Windows tablets?
No. The Butterfly app is currently limited to iOS and specific Android devices. If your facility relies on Windows-based tablets (such as the Surface Pro) for EMR integration or viewing, you will need to consider alternatives like the Suresult D3-Ultra, which offers native Windows compatibility.